Kyung Dong Pharmaceutical Co. Ltd (011040) — Cash Flow Reinvestment Rate
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Cash Flow Reinvestment Rate of 0.45x as of March 2026, reinvesting ₩2.56 Billion (capex ₩1.84 Billion plus investments ₩-714.46 Million) from operating cash flow of ₩5.70 Billion. Check 011040 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kyung Dong Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Kyung Dong Pharmaceutical Co. Ltd across 11 annual periods. Explore 011040 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Year-by-year capital reinvestment analysis for Kyung Dong Pharmaceutical Co. Ltd. For live market cap and broader valuation context, see market cap of Kyung Dong Pharmaceutical Co. Ltd.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.03x | ₩34.36 Billion | ₩16.93 Billion | ₩20.51 Billion | ▲ +56.8% |
| 2021 | 1.29x | ₩16.07 Billion | ₩12.42 Billion | ₩3.93 Billion | ▼ -57.5% |
| 2020 | 3.05x | ₩52.12 Billion | ₩17.12 Billion | ₩28.59 Billion | ▲ +339.0% |
| 2018 | 0.69x | ₩23.07 Billion | ₩33.27 Billion | ₩3.93 Billion | ▲ +15.7% |
| 2017 | 0.60x | ₩8.86 Billion | ₩14.79 Billion | ₩5.74 Billion | ▲ +27.1% |
| 2016 | 0.47x | ₩12.09 Billion | ₩25.63 Billion | ₩7.19 Billion | ▼ -43.6% |
| 2015 | 0.84x | ₩15.27 Billion | ₩18.26 Billion | ₩11.10 Billion | ▼ -11.7% |
| 2014 | 0.95x | ₩21.53 Billion | ₩22.73 Billion | ₩21.17 Billion | ▲ +65.8% |
| 2013 | 0.57x | ₩9.38 Billion | ₩16.42 Billion | ₩9.38 Billion | ▲ +61.4% |
| 2012 | 0.35x | ₩7.06 Billion | ₩19.96 Billion | ₩7.06 Billion | ▲ +277.9% |
| 2011 | 0.09x | ₩2.44 Billion | ₩26.08 Billion | ₩2.44 Billion | — |